Envoy Medical COCH Offering Costs From The Issuance Of Class A Common Stock And Investor Warrants From Registered
Offering Costs From The Issuance Of Class A Common Stock And Investor Warrants From Registered at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept coch:OfferingCostsFromTheIssuanceOfClassACommonStockAndInvestorWarrantsFromRegistered.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's offering costs from the issuance of class a common stock and investor warrants from registered.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's offering costs from the issuance of class a common stock and investor warrants from registered?
- Envoy Medical (COCH) reported offering costs from the issuance of class a common stock and investor warrants from registered of $2.22M in Q1 2026.
- How has Envoy Medical's offering costs from the issuance of class a common stock and investor warrants from registered changed year-over-year?
- Envoy Medical's offering costs from the issuance of class a common stock and investor warrants from registered increased by 1053.6% year-over-year, from $192K to $2.22M.
- What does offering costs from the issuance of class a common stock and investor warrants from registered mean?
- Direct costs incurred in the process of issuing common stock and associated investor warrants, such as underwriting fees, legal expenses, and registration costs. This metric measures the friction costs of raising equity capital. High costs relative to proceeds may indicate inefficiencies in the capital-raising process.